ISPOR - HTA90 Consideration of Off-Label Therapies as Appropriate Comparator Therapy in Early Benefit Assessments in Germany Under the ALBVVG Legislation

Full Text

HTA90 Consideration of Off-Label Therapies as Appropriate Comparator Therapy in Early Benefit Assessments in Germany Under the ALBVVG Legislation

Abstract

Authors

Susanne Brückel Wioletta Kotowa

Back to Volume 28, Supplemental Issue 12S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now